IVD Raw Materials Market, By Product (Antibodies & Antigens, Enzymes, Proteins, Biological Buffers, and Others), By Technology (Clinical Chemistry, Immunochemistry, Molecular diagnostics, and Others), By End-User (Pharma, Biotech & MedTech Companies, Diagnostic Laboratories, and Others), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
In vitro diagnostics can detect diseases/conditions, and can be used to monitor overall health to help cure, treat, and/or prevent diseases. In vitro diagnostics are utilized to diagnose a wide range of medical disorders, such as cardiovascular disease, cancer, diabetes, infectious disease, nephrology, autoimmune diseases, and HIV/AIDS. IVD are tests done on the blood sample or tissue sample that have been taken from the human body. In short, IVD raw materials used to determine the status of a person's health. The core raw materials of in vitro diagnostic (IVD) reagents/kits include antibodies, antigens, enzymes, etc., which are important determinants of the quality and effectiveness of the reagents/kits.
Market Dynamics:
The outbreak of COVID-19, high prevalence of chronic diseases, advanced technologies in in vitro diagnostic products, rise in use of point-of-care diagnostics, rising geriatric population, and growing significance of companion diagnostics are some major factors expected to boost the growth of the global IVD raw materials market during the forecast period.
In August 2021, Roche received the U.S. Food and Drug Administration (FDA) approval for VENTANA MMR RxDx Panel to identify dMMR solid tumor patients eligible for anti-PD-1 immunotherapy. Moreover, in May 2020, ERBA Diagnostics Mannheim GmbH announced the launch of its immunoassay-based kit, ErbaLisa COVID-19 ELISA kits, for the detection of IgG and IgM antibodies to SARS-CoV-2. In March 2020, Abbott launched the RealTime SARS-CoV-2 assay, a PCR-based test, for the diagnosis of COVID-19, and BioMedomics launched a point-of-care COVID-19 test that can detect antibodies in blood within 15 minutes.
Key features of the study:
Table of Contents: 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description Market Definition and Scope o Executive Summary Market Snapshot, By Product Market Snapshot, By Technology Market Snapshot, By End User Market Snapshot, By Geography o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics High prevalence of chronic diseases across the world Stringent regulations regarding product approvals Increase in the use of point-of-care (POC) diagnostics o Impact Analysis o Key Highlights o Regulatory Scenario o Product launch/Approvals o PEST Analysis o PORTER’s Analysis o Merger and Acquisition Scenario 4. Global IVD Raw Materials Market Market – Impact of Coronavirus (COVID-19) Pandemic o COVID-19 Epidemiology o Supply Side and Demand Side Analysis o Economic Impact 5. Global IVD Raw Materials Market, By Product, 2017-2028, (US$ Mn) o Introduction Market Share Analysis, 2022 and 2028 (%) Y-o-Y Growth Analysis, 2017 – 2028 Segment Trends o Antibodies & Antigens Introduction Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn) o Enzymes Introduction Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn) o Proteins Introduction Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn) o Biological Buffers Introduction Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn) o Others Introduction Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn) 6. Global IVD Raw Materials Market, Technology, 2017-2028, (US$ Mn) o Introduction Market Share Analysis, 2022 and 2028 (%) Y-o-Y Growth Analysis, 2017 – 2028 Segment Trends o Clinical Chemistry Introduction Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn) o Immunochemistry Introduction Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn) o Molecular diagnostics Introduction Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn) o Others Introduction Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn) 7. Global IVD Raw Materials Market, By End User, 2017-2028, (US$ Mn) o Introduction Market Share Analysis, 2022 and 2028 (%) Y-o-Y Growth Analysis, 2017 – 2028 Segment Trends o Pharma, Biotech & MedTech Companies Introduction Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn) o Diagnostic Laboratories Introduction Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn) o Others Introduction Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn) 8. Global IVD Raw Materials Market, By Geography, 2017-2028, (US$ Mn) o Introduction Market Share Analysis, 2022 and 2028 (%) Y-o-Y Growth Analysis, 2017 – 2028 Segment Trends o North America Introduction Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn) Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn) o Europe Introduction Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn) Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn) o Asia Pacific Introduction Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn) Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn) o Latin America Introduction Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn) Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn) o Middle East and Africa Introduction Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn) Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn) o Rest of World Introduction Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn) Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn) 9. Competitive Landscape o Aalto Bio Reagents Company Highlights Product Portfolio Key Developments Financial Performance Strategies o Fapon Biotech Company Highlights Product Portfolio Key Developments Financial Performance Strategies o Fujirebio Company Highlights Product Portfolio Key Developments Financial Performance Strategies o Merck KgaA Company Highlights Product Portfolio Key Developments Financial Performance Strategies o Hoffmann-La Roche Company Highlights Product Portfolio Key Developments Financial Performance Strategies o Thermo Fisher Scientific Company Highlights Product Portfolio Key Developments Financial Performance Strategies o Analyst Views 10. Section o Research Methodology o About us *Browse 24 market data tables and 28 figures on "Global IVD Raw Materials Market” - forecast to 2028
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook